ESR1 and cancer: Estrogen receptor (ER), which is often directly implicated in cancer development, provides the basis for two types of anti-hormone therapy: selective estrogen receptor modulators (SERMs), such as tamoxifen, and selective estrogen receptor degraders (SERDs), such as fulvestrant [31].